Trials / Completed
CompletedNCT00436137
Improving Followup of Abnormal Colon Cancer Screening Tests
Improving Followup of Positive Fecal Occult Blood Tests
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Harvard Vanguard Medical Associates · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether direct mailings to patients with positive fecal occult blood tests can increase rates of performing followup colonoscopy.
Detailed description
Screening programs using the fecal occult blood test (FOBT) have demonstrated a significant reduction in colorectal cancer mortality, although only when accompanied by a complete diagnostic evaluation of the colon in the setting of a positive result. 90% of patients with a positive FOBT result have completed a subsequent colonoscopy within Harvard Vanguard Medical Associates. This project will use a pre-post study design to increase the rate of followup colonoscopy in the setting of positive FOBT results. Patients in the intervention group will receive a personalized mailing highlighting their positive result and need for colonoscopy, followed by telephone outreach from a centralized gastroenterology scheduling office. The primary outcome will be the performance of colonoscopy, however we will also perform chart reviews to identify predictors of completing appropriate followup.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Patient mailing | Patient will receive a mailing recommending colonoscopy, followed by telephone outreach |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2007-02-16
- Last updated
- 2008-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00436137. Inclusion in this directory is not an endorsement.